Skip to main content

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Davis' full profile

Already have an account?

  • Office

    1269 Wellbrook Cir NE
    Conyers, GA 30012
    Phone+1 770-922-0505
    Fax+1 770-922-1870

Summary

  • Dr. Eric Davis is a gastroenterologist in Conyers, GA and is affiliated with multiple hospitals in the area, including Piedmont Rockdale Hospital, Piedmont Rockdale Hospital, and Piedmont Newton Hospital. He received his medical degree from Meharry Medical College and has been in practice 6 years.

Education & Training

  • University of Mississippi Medical Center
    University of Mississippi Medical CenterFellowship, Gastroenterology, 2017
  • University of Mississippi Medical Center
    University of Mississippi Medical CenterResidency, Internal Medicine, 2011 - 2014
  • Meharry Medical College
    Meharry Medical CollegeClass of 2011
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicinePost-Doctoral Fellowship, Motility

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2017 - 2026
  • MS State Medical License
    MS State Medical License 2014 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

Abstracts/Posters

  • Predictive Factors of Response and Survival of Lenalidomide and Rituximab As Initial Treatment of Follicular Lymphoma
    Eric Davis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma...
    Eric Davis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Results of a First in Human, Dose Ascending, Phase I Study Examining the Safety and Tolerability of KA2237, an Oral PI3K p110_/_ Inhibitor in Patients with Relapsed/Re...
    Eric Davis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all